[Form 4/A] INNOSPEC INC. Amended Insider Trading Activity
INNOSPEC INC. director Milton C. Blackmore reported amended details of recent stock sales.
Rhea-AI Filing Summary
INNOSPEC INC. director Milton C. Blackmore reported amended details of recent stock sales. On February 27, 2026, he completed two open-market sales of the company’s common stock totaling 594 shares. One block of 287 shares was sold at a weighted average price of $76.30 per share, and another 307 shares at a weighted average price of $76.79 per share. After these transactions, his directly held stake changed in two steps to 10,837 shares and then 10,530 shares of common stock. This amended Form 4 corrects previously reported transaction prices and notes that the sale prices reflect weighted averages across multiple trades within stated ranges.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 287 | $76.30 | $22K |
| Sale | Common Stock | 307 | $76.79 | $24K |
Footnotes (2)
- F1. This Form 4/A amends the Form 4 filed on March 3, 2026 to correct the transaction price reported in Table I. The price reported reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from $75.5001 to $76.55. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This Form 4/A amends the Form 4 filed on March 3, 2026 to correct the transaction price reported in Table I. The price reported reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from $76.555 to $77.0713. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did INNOSPEC (IOSP) report for Milton C. Blackmore?
What was Milton C. Blackmore’s INNOSPEC (IOSP) ownership after these Form 4/A sales?
Why was this INNOSPEC (IOSP) Form 4/A filed as an amendment?
What price ranges are disclosed for Milton C. Blackmore’s INNOSPEC (IOSP) stock sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.